Z. Horváth

发表

A phase II open-label trial of avelumab plus axitinib in previously treated non-small-cell lung cancer or treatment-naïve, cisplatin-ineligible urothelial cancer

B. Cho, R. Hauke, I. Lugowska, 2023, ESMO open.

Cetuximab, gemcitabine and capecitabine in patients with inoperable biliary tract cancer: a phase 2 study.

Z. Szentirmay, E. Hitre, I. Láng, 2013, European journal of cancer.